NCT06976034Recruiting
oCular Examination at Cell RESolution With Optical TransmissionTomography
Source: ClinicalTrials.gov · Last updated 16 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Understanding the pathogenesis of eye diseases has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems, such as optical coherence tomography (OCT), are limited in terms of resolution, acquisition speed or access to certain eye functions. Our team has participated in the development of a new generation of imaging technology known as optical transmission tomography (OTT), which enables imaging of the anterior parts of the eye with high cellular resolution, a wide field of view and reduced examination delay.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 2 May 2025
- Start date
- 12 Nov 2024
- Primary completion date
- 12 Nov 2029
- Lead sponsor
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- Diseases
- Glaucoma
- NCT number
- NCT06976034
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 12 Nov 2024 to the primary completion date, 12 Nov 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Conjunctivitis or other contagious contact disease in active phase;
Other
- For all participants:
- Inability to hold a still position on a standard ophthalmic chin rest;
- Having an implanted pacemaker or other electronic medical device;
- Having a predisposition to iridocorneal angle closure;
- Vulnerable persons or persons under legal protection (pregnant or breast-feeding women; persons under guardianship,
Who the study is looking for
- For Patients:
- 200 subjects aged 18 to 80 years;
- Male or female;
- with an ocular disease affecting the cornea, ocular surface, lens (cataract) or glaucoma, or requiring refractive surgery or post-refractive surgery follow-up;
- Are covered by the French Assurance Maladie;
- Have signed an express, free and informed consent form.
- For Healthy volunteers:
- 100 subjects aged 18 to 80 years;
- Male or female;
- Healthy subjects with no known pathology directly or indirectly affecting ocular structures;
- Covered by the French Assurance Maladie.
- Having signed an express, free and informed consent form.
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier National D'ophtalmologie Des Quinze Vingts Coordinator of this site? Confirm its status | Paris | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.